Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00262470 · ClinicalTrials.gov registry record · Phase 1
Treatment of Orthostatic Intolerance
A Phase 1 study of Tachycardia and Chronic Orthostatic Intolerance, sponsored by Satish R. Raj.
- Active
- Registry status
- Phase 1
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT00262470 is a Phase 1 study of Tachycardia and Chronic Orthostatic Intolerance that is active but no longer recruiting, run by Satish R. Raj. The registered enrollment target is 150 participants, below the 880-participant average among 8 other Tachycardia trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00262470, a Phase 1 study of Tachycardia and Chronic Orthostatic Intolerance, is active but no longer recruiting, sponsored by Satish R. Raj.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder.
Conditions Studied
Interventions
- DRUG Acetazolamide
- DRUG Atomoxetine
- DRUG Clonidine
- OTHER NO Drug
- DRUG Entacapone
Study Locations (1)
Tennessee
- Vanderbilt University Autonomic Dysfunction Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 1997-04 |
| Est. Completion | 2029-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00262470
The ClinicalTrials.gov registry entry for NCT00262470 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 880-participant average among 8 other Tachycardia trials with a reported enrollment target (83% lower). The listed sponsor is Satish R. Raj, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tachycardia appearing as the primary indexed condition, and to 5 interventions - of which Acetazolamide is the first listed.
NCT00262470 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00262470 about?
NCT00262470 is a clinical study titled "Treatment of Orthostatic Intolerance". This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder.
What is the current status of trial NCT00262470?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 1997-04. Estimated completion is 2029-12.
What conditions does trial NCT00262470 study?
This clinical trial studies the following conditions: Tachycardia, Chronic Orthostatic Intolerance.
What interventions are being tested in trial NCT00262470?
The interventions under investigation include: Acetazolamide (DRUG), Atomoxetine (DRUG), Clonidine (DRUG), NO Drug (OTHER), Entacapone (DRUG).
Who is sponsoring clinical trial NCT00262470?
This trial is sponsored by Satish R. Raj, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00262470 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
ACTIVE NOT RECRUITING
-
Enlighten Study: The EV-ICD Post Approval Registry
ACTIVE NOT RECRUITING
-
Pathophysiology of Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
Cardiac Implantable Electronic Device (CIED) Research Study
ACTIVE NOT RECRUITING
-
RIGHT: Rhythm ID Going Head-to-Head Trial
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.